Angioplasty, Coronary disease, Cost-benefit analysis, Hypercholesterolemia
dx.doi.org/10.1345/aph.1E367, hdl.handle.net/1765/67596
The Annals of Pharmacotherapy
Department of Cardiology

Delea, T.E, Jacobson, T.A, Serruys, P.W.J.C, Edelsberg, J.S, & Oster, G. (2005). Cost-effectiveness of fluvastatin following successful first percutaneous coronary intervention. The Annals of Pharmacotherapy, 39(4), 610–616. doi:10.1345/aph.1E367